Follow Chr. Hansen A/S

Tags

Chr. Hansen 78 probiotics 17 dairy 14 food 14 consumers 11 Natural Colors 9 beverage 7 cheese 5 communication 4 innovation 4 bb-12® 4 Q2 3 lgg® 3 microbiome 3 images 3 marketing 3 annual report 3 press 2 poultry 2 animal health 2 financial results 2 agriculture 2 Cees de Jong 2 lactose-free 2 lactose 2 award 2 financial report 2 yogurt 2 lactose intolorant 2 interim report 2 C20 2 feed 2 food and beverage 1 sugar 1 transparency 1 probiotic 1 ingredients 1 organizational 1 natural solutions 1 conversion 1 cottage cheese 1 regnskab 1 Lonza 1 H1 1 game changer 1 food waste 1 dietary supplements 1 valio 1 idf 1 label 1 colors 1 product 1 financials 1 dial 1 natural colours 1 innovation center 1 ultra stable red 1 confectionary 1 infant formula 1 kefir 1 carmine 1 human microbiome 1 second generation 1 financial result 1 cultures 1 l.casei 431 1 white cheese 1 greek feta 1 direct vat set 1 fermentation 1 ripening culture 1 GalliPro® Max 1 microbial 1 dairy alternatives 1 plant health 1 soft cheese 1 fermented 1 2016/17 1 plant based 1 UN goals 1 bioprotection 1 FreshQ 1 Natural color 1 coloring foodstuff 1 natural colour 1 colouring foodstuff 1 LGG 1 childrens' product 1 drinking yogurt 1 communincation 1 dvs white classic 1 DVS® FRESCO® 1000 1 SCiO 1 Consumer Physics 1 feed analysis 1 Q2 2017/18 1 sustainability 1 test 1 salt 1 iso 1 standard 1 clinical trial 1 growth 1 new 1 acquisition 1 clean 1 corporate responsibility 1 wine 1 Q1 1 flow cytometry 1 cfo 1 joint venture 1 change 1 bacteria 1 children 1 financial 1 leadership 1 culture 1 kids 1 livestock 1 report 1 results 1 natural 1 delight 1 pet food 1 quarterly result 1 q3 1 Show all tags

Latest news

Chr. Hansen’s Head of Sustainability recognized as Meaningful Business 100 Leader

Chr. Hansen’s Head of Sustainability recognized as Meaningful Business 100 Leader

Press releases   •   Nov 06, 2019 12:09 UTC

Global platform brings together the top 100 business leaders who are combining profit and purpose to help achieve the UN Sustainable Development Goals

Chr. Hansen reaches 7% organic growth in 2018/19

Chr. Hansen reaches 7% organic growth in 2018/19

Press releases   •   Oct 10, 2019 06:28 UTC

Despite more challenging growth conditions Chr. Hansen delivers a strong EBIT margin and a healthy cash flow, while also making significant progress on key strategic priorities

Chr. Hansen’s good bacteria to be produced on solar power

Chr. Hansen’s good bacteria to be produced on solar power

Press releases   •   Sep 23, 2019 08:07 UTC

A new 10-year agreement enables Chr. Hansen Denmark to switch 100% to green power from two brand new solar parks. The agreement underlines Chr. Hansen’s commitment to a sustainable future and will create more green energy capacity to the benefit of all of Denmark.

Chr. Hansens gode bakterier skal fremstilles på solenergi

Chr. Hansens gode bakterier skal fremstilles på solenergi

Press releases   •   Sep 23, 2019 08:02 UTC

En ny tiårig aftale med Better Energy betyder, at Chr. Hansen kan overgå 100% til grøn strøm fra to helt nye solcelleparker. Aftalen understreger Chr. Hansens dedikation til en bæredygtig fremtid og skaber mere grøn energi til hele Danmark.

Chr. Hansen and Lonza’s newly branded joint venture, BacThera, receives anti-trust approvals to start contract manufacturing of live biotherapeutic products

Chr. Hansen and Lonza’s newly branded joint venture, BacThera, receives anti-trust approvals to start contract manufacturing of live biotherapeutic products

Press releases   •   Aug 29, 2019 13:52 UTC

​Chr. Hansen Holding A/S, a leading global bioscience company, and Lonza AG, a leading pharma contract manufacturing company, announce today that they have received the relevant approvals from anti-trust regulators needed to establish the 50/50 joint venture in the emerging market for live biotherapeutic products, which was originally announced in Company Announcement No. 04 on April 2, 2019.

Chr. Hansen and Lonza’s newly branded joint venture, BacThera, receives anti-trust approvals to start contract manufacturing of live biotherapeutic products

Chr. Hansen and Lonza’s newly branded joint venture, BacThera, receives anti-trust approvals to start contract manufacturing of live biotherapeutic products

News   •   Aug 29, 2019 09:16 UTC

​Chr. Hansen Holding A/S, a leading global bioscience company, and Lonza AG, a leading pharma contract manufacturing company, announce today that they have received the relevant approvals from anti-trust regulators needed to establish the 50/50 joint venture in the emerging market for live biotherapeutic products, which was originally announced in Company Announcement No. 04 on April 2, 2019.

Chr. Hansen gearer op til en bæredygtig fremtid

Chr. Hansen gearer op til en bæredygtig fremtid

Press releases   •   Aug 29, 2019 07:39 UTC

Den globale bioscience virksomhed udvider og styrker forskning- & udviklingsfaciliteterne i Hørsholm for at imødekomme den stigende efterspørgsel efter naturlige og bæredygtige produkter.

Chr. Hansen gears up for a sustainable future

Chr. Hansen gears up for a sustainable future

Press releases   •   Aug 29, 2019 07:38 UTC

Global bioscience company Chr. Hansen to expand and strengthen its research & development facilities north of Copenhagen to meet the increasing demand for natural and sustainable products.

Endnu en influenzasæson er på trapperne, men ny forskning har afsløret et hemmeligt våben, der kan nedbringe omkostningerne ved influenza-lignende sygdom

Endnu en influenzasæson er på trapperne, men ny forskning har afsløret et hemmeligt våben, der kan nedbringe omkostningerne ved influenza-lignende sygdom

Press releases   •   Aug 28, 2019 07:48 UTC

En ny sundhedsøkonomisk undersøgelse har påvist, at indtagelsen af probiotika kan bidrage til at reducere omkostningerne forbundet med influenza-lignende sygdom. Alene i USA kan indtagelsen af probiotika nedbringe antallet af sygedage med over 54 millioner dage om året, ifølge undersøgelsen.

As the dreaded flu-season knocks on our door, a new study reveals a secret weapon to reduce the cost of flu-like sickness

As the dreaded flu-season knocks on our door, a new study reveals a secret weapon to reduce the cost of flu-like sickness

Press releases   •   Aug 28, 2019 07:22 UTC

A new health economics study shows that the intake of probiotics can help reduce the cost of flu-like sickness. In the US alone, taking probiotics can reduce the number of sick days by over 54 million days per year, according to the study.

Solid sales growth and profitability in Q3, but reduced organic growth outlook for the year

Solid sales growth and profitability in Q3, but reduced organic growth outlook for the year

Press releases   •   Jun 26, 2019 17:57 UTC

Chr. Hansen delivers a solid financial result of 9% organic growth for the first nine months, but adjusts full-year organic growth​ outlook from 9-11% to 7-8%

Groundbreaking ‘sweet’ culture reduces added sugar in fermented dairy products

Groundbreaking ‘sweet’ culture reduces added sugar in fermented dairy products

Press releases   •   May 08, 2019 08:40 UTC

Chr. Hansen launches Sweety® Y-1: The first culture in the world allowing dairy manufacturers to create naturally sweeter products while reducing added sugar

Game-changing coagulant enables up to one percent yield increase

Game-changing coagulant enables up to one percent yield increase

Press releases   •   Apr 03, 2019 07:17 UTC

Chr. Hansen launches CHY-MAX® Supreme - the most precise and innovative coagulant on the market with superior functionality for modern cheesemakers

Solid momentum continues: 9% organic growth in the first 6 months of 2018/19

Solid momentum continues: 9% organic growth in the first 6 months of 2018/19

Press releases   •   Apr 03, 2019 06:08 UTC

Solid momentum continues: 9% organic growth in the first 6 months of 2018/19 Chr. Hansen delivers solid half-year result of 9% organic growth and maintains overall outlook for the full year. The growth comes from all business areas: Food Cultures & Enzymes 10%, Health & Nutrition 11% and Natural Colors 5%

Chr. Hansen in joint venture to accelerate momentum in microbiome

Chr. Hansen in joint venture to accelerate momentum in microbiome

Press releases   •   Apr 02, 2019 15:31 UTC

Chr. Hansen in joint venture to accelerate momentum in microbiome Danish bioscience company, Chr. Hansen, joins forces with Lonza AG to pioneer the emerging market for live biotherapeutic products

World’s best documented probiotic now available for fermented plant bases

World’s best documented probiotic now available for fermented plant bases

Press releases   •   Feb 28, 2019 14:44 UTC

Chr. Hansen launches nu-trish® LGG® DA to further improve the health appeal of fermented plant bases

Introducing the Hansen sweet potato™ – the secret behind the market’s best carmine alternative

Introducing the Hansen sweet potato™ – the secret behind the market’s best carmine alternative

Press releases   •   Feb 19, 2019 07:00 UTC

Chr. Hansen’s decade-long breeding program results in a new and unique sweet potato that is the raw material creating vibrant alternatives to carmine and synthetic reds

Chr. Hansen kåret som verdens mest bæredygtige virksomhed

Chr. Hansen kåret som verdens mest bæredygtige virksomhed

Press releases   •   Jan 22, 2019 05:07 UTC

Chr. Hansen topper 2019-ranglisten over verdens 100 mest bæredygtige virksomheder, som offentliggjort under World Economic Forum i Davos i Schweiz.

Chr. Hansen ranked as the most sustainable company in the world

Chr. Hansen ranked as the most sustainable company in the world

Press releases   •   Jan 22, 2019 05:00 UTC

Topping the 2019 global index of the 100 most sustainable companies, as announced during the World Economic Forum in Davos, Switzerland.

Solid start to the year: 10% organic growth

Solid start to the year: 10% organic growth

Press releases   •   Jan 17, 2019 07:08 UTC

Chr. Hansen realizes solid organic growth of 10% in the first three months of the financial year 2018/19, delivering in line with our 'Nature’s no. 1 – Sustainably' growth ambitions.